LGALS1 and glioblastoma: The significant overexpression of Gal-1 in these cancers including cholangiocarcinoma (CHOL), diffuse large B-cell carcinoma (DLBCL), esophageal carcinoma (ESCA), glioblastoma (GBM), head and neck squamous cell carcinoma (HNSC), pancreas adenocarcinoma (PAAD) and in thymoma (THYM).